Multimodality molecular imaging of the lung

Journal of Magnetic Resonance Imaging

Volumn 32, Issue 6, 2010, Pages 1409-1420

  Chen, Delphine L ^a   Kinahan, Paul E ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

lung imaging; molecular imaging; MR PET; multimodality imaging; PET CT; SPECT CT

Indexed keywords

BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18;

COMPUTER ASSISTED TOMOGRAPHY; LUNG; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION ATTENUATION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BRONCHIOLES; DIAGNOSTIC IMAGING; HUMANS; IMAGING, THREE-DIMENSIONAL; LUNG; LUNG DISEASES; MODELS, ANATOMIC; RESPIRATION;

EID: 78649646574     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22385     Document Type: Review

References (80)

1. Mankoff DM., A definition of molecular imaging. J Nucl Med 2007; 48: 18N-19N.
2. Schuster DP, Blackwell T, (eds.). Lung biology in health and disease. Boca Raton, FL: Taylor & Francis; 2005.
3. Stanbrook MB, Corey M, Tullis DE., The repeatability of forced expiratory volume measurements in adults with cystic fibrosis. Chest 2004; 125: 150-155.
4. Glenny RW., Determinants of regional ventilation and blood flow in the lung. Intensive Care Med 2009; 35: 1833-1842.
5. Harris RS, Winkler T, Tgavalekos N, et al. Regional pulmonary perfusion, inflation, and ventilation defects in bronchoconstricted patients with asthma. Am J Respir Crit Care Med 2006; 174: 245-253.
6. Tgavalekos NT, Tawhai M, Harris RS, et al. Identifying airways responsible for heterogeneous ventilation and mechanical dysfunction in asthma: an image functional modeling approach. J Appl Physiol 2005; 99: 2388-2397.
7. Fazio F, Jones T, MacArthur CG, Rhodes CG, Steiner RE, Hughes JM., Measurement of regional pulmonary oedema in man using radioactive water (H215O). Br J Radiol 1976; 49: 393-397.
8. Schuster DP, Anderson C, Kozlowski J, Lange N., Regional pulmonary perfusion in patients with acute pulmonary edema. J Nucl Med 2002; 43: 863-870.
9. Wollmer P, Rhodes CG, Allan RM, Maseri A, Fazio F., Regional extravascular lung density and fractional pulmonary blood volume in patients with chronic pulmonary venous hypertension. Clin Physiol 1983; 3: 241-256.
10. Wollmer P, Rhodes CG, Deanfield J, et al. Regional extravascular density of the lung in patients with acute pulmonary edema. J Appl Physiol 1987; 63: 1890-1895.
11. Wollmer P, Rhodes CG, Hughes JM., Regional extravascular density and fractional blood volume of the lung in interstitial disease. Thorax 1984; 39: 286-293.
12. Kaplan JD, Trulock EP, Anderson DJ, Schuster DP., Pulmonary vascular permeability in interstitial lung disease. A positron emission tomographic study. Am Rev Respir Dis 1992; 145: 1495-1498.
13. Kaplan JD, Trulock EP, Cooper JD, Schuster DP., Pulmonary vascular permeability after lung transplantation. A positron emission tomographic study. Am Rev Respir Dis 1992; 145: 954-957.
14. Ueki J, Rhodes CG, Hughes JM, et al. In vivo quantification of pulmonary beta-adrenoceptor density in humans with (S)-[11C]CGP-12177 and PET. J Appl Physiol 1993; 75: 559-565.
15. Chen DL, Ferkol TW, Mintun MA, Pittman JE, Rosenbluth DB, Schuster DP., Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. Am J Respir Crit Care Med 2006; 173: 1363-1369.
16. Jones HA, Marino PS, Shakur BH, Morrell NW., In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur Respir J 2003; 21: 567-573.
17. Jones HA, Cadwallader KA, White JF, Uddin M, Peters AM, Chilvers ER., Dissociation between respiratory burst activity and deoxyglucose uptake in human neutrophil granulocytes: implications for interpretation of (18)F-FDG PET images. J Nucl Med 2002; 43: 652-657.
18. Cherry SR, Sorenson JA, Phelps ME., Physics in nuclear medicine, 3rd ed. Philadelphia: Saunders; 2003.
19. Huang SC,. Anatomy of SUV. Standardized uptake value. Nucl Med Biol 2000; 27: 643-646.
20. Thie JA,. Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med 2004; 45: 1431-1434.
21. Boellaard R,. Standards for PET image acquisition and quantitative data analysis. J Nucl Med 2009; 50: 11S-120.
22. Kinahan PE, Doot RK, Wanner-Roybal M, et al. PET/CT assessment of response to therapy: tumor change measurement, truth data, and error. Transl Oncol 2009; 2: 223-230.
23. Mai VM, Knight-Scott J, Berr SS., Improved visualization of the human lung in 1H MRI using multiple inversion recovery for simultaneous suppression of signal contributions from fat and muscle. Magn Reson Med 1999; 41: 866-870.
24. Biederer J, Reuter M, Both M, et al. Analysis of artefacts and detail resolution of lung MRI with breath-hold T1-weighted gradient-echo and T2-weighted fast spin-echo sequences with respiratory triggering. Eur Radiol 2002; 12: 378-384.
25. Chen DL, Mintun MA, Schuster DP., Comparison of methods to quantitate 18F-FDG uptake with PET during experimental acute lung injury. J Nucl Med 2004; 45: 1583-1590.
26. Patlak CS, Blasberg RG., Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 1985; 5: 584-590.
27. Patlak CS, Blasberg RG, Fenstermacher JD., Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3: 1-7.
28. Huang SC, Phelps ME., Principles of tracer kinetic modeling in positron emission tomography and autoradiography. In:, Phelps ME, Mazziotta JC, Schelbert HR, eds. Positron emission tomography and autoradiography: principles and applications for the brain and heart. New York: Raven Press; 1986. p 287-346.
29. Jones HA, Sriskandan S, Peters AM, et al. Dissociation of neutrophil emigration and metabolic activity in lobar pneumonia and bronchiectasis. Eur Respir J 1997; 10: 795-803.
30. Bellani G, Messa C, Guerra L, et al. Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: a [18F]-fluoro-2-deoxy-D-glucose PET/CT study. Crit Care Med 2009; 37: 2216-2222.
31. Chen DL, Rosenbluth DB, Mintun MA, Schuster DP., FDG-PET imaging of pulmonary inflammation in healthy volunteers after airway instillation of endotoxin. J Appl Physiol 2006; 100: 1602-1609.
32. Chen DL, Schuster DP., Positron emission tomography with [18F]fluorodeoxyglucose to evaluate neutrophil kinetics during acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004; 286: L834-40.
33. Jones HA, Donovan T, Goddard MJ, et al. Use of 18FDG-pet to discriminate between infection and rejection in lung transplant recipients. Transplantation 2004; 77: 1462-1464.
34. Schroeder T, Vidal Melo MF, Musch G, Harris RS, Venegas JG, Winkler T., Modeling pulmonary kinetics of 2-deoxy-2-[18F]fluoro-D-glucose during acute lung injury. Acad Radiol 2008; 15: 763-775.
35. Lammertsma AA., Measurement of tumor response using [18F]-2-fluoro-2- deoxy-D-glucose and positron-emission tomography. J Clin Pharmacol 2001;(Suppl): 104S-106S.
36. Gilman MD, Fischman AJ, Krishnasetty V, Halpern EF, Aquino SL., Optimal CT breathing protocol for combined thoracic PET/CT. Am J Roentgenol 2006; 187: 1357-1360.
37. Goerres GW, Kamel E, Heidelberg TN, Schwitter MR, Burger C, von Schulthess GK., PET-CT image co-registration in the thorax: influence of respiration. Eur J Nucl Med Mol Imaging 2002; 29: 351-360.
38. Kawano T, Ohtake E, Inoue T,. Deep-inspiration breath-hold PET/CT of lung cancer: maximum standardized uptake value analysis of 108 patients. J Nucl Med 2008; 49: 1223-1231.
39. Liu C, Pierce LA 2nd, Alessio AM, Kinahan PE,. The impact of respiratory motion on tumor quantification and delineation in static PET/CT imaging. Phys Med Biol 2009; 54: 7345-7362.
40. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41: 1369-1379.
41. Kinahan PE, Hasegawa BH, Beyer T., X-ray based attenuation correction for PET/CT scanners. Semin Nucl Med 2003; 33: 166-179.
42. Kinahan PE, Townsend DW, Beyer T, Sashin D., Attenuation correction for a combined 3D PET/CT scanner. Med Phys 1998; 25: 2046-2053.
43. Takasawa M, Jones PS, Guadagno JV, et al. How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke 2008; 39: 870-877.
44. Cherry SR, Louie AY, Jacobs RE., The integration of positron emission tomography with magnetic resonance imaging. Proc IEEE 2008; 96: 416-438.
45. Taylor IK, Hill AA, Hayes M, et al. Imaging allergen-invoked airway inflammation in atopic asthma with [18F]-fluorodeoxyglucose and positron emission tomography. Lancet 1996; 347: 937-940.
46. Chen DL, Bedient TJ, Kozlowski J, et al. [18F]fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation. Am J Respir Crit Care Med 2009; 180: 533-539.
47. Pio BS, Byrne FR, Aranda R, et al. Noninvasive quantification of bowel inflammation through positron emission tomography imaging of 2-deoxy-2-[18F]fluoro-D-glucose-labeled white blood cells. Mol Imaging Biol 2003; 5: 271-277.
48. Rini JN, Bhargava KK, Tronco GG, et al. PET with FDG-labeled leukocytes versus scintigraphy with 111In-oxine-labeled leukocytes for detection of infection. Radiology 2006; 238: 978-987.
49. Dumarey N, Egrise D, Blocklet D, et al. Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. J Nucl Med 2006; 47: 625-632.
50. Rini JN, Palestro CJ., Imaging of infection and inflammation with 18F-FDG-labeled leukocytes. Q J Nucl Med Mol Imaging 2006; 50: 143-146.
51. Locke LW, Chordia MD, Zhang Y, et al. A novel neutrophil-specific PET imaging agent: cFLFLFK-PEG-64Cu. J Nucl Med 2009; 50: 790-797.
52. Siaens RH, Rennen HJ, Boerman OC, Dierckx R, Slegers G., Synthesis and comparison of 99mTc-enrofloxacin and 99mTc-ciprofloxacin. J Nucl Med 2004; 45: 2088-2094.
53. Klein M, Cohen-Cymberknoh M, Armoni S, et al. 18F-fluorodeoxyglucose-PET/ CT imaging of lungs in patients with cystic fibrosis. Chest 2009; 136: 1220-1228.
54. Dolovich M, Labiris R., Imaging drug delivery and drug responses in the lung. Proc Am Thorac Soc 2004; 1: 329-337.
55. Dolovich MB., Measuring total and regional lung deposition using inhaled radiotracers. J Aerosol Med 2001; 14 (Suppl 1): S35-44.
56. Tetzlaff R, Schwarz T, Kauczor HU, Meinzer HP, Puderbach M, Eichinger M., Lung function measurement of single lungs by lung area segmentation on 2D dynamic MRI. Acad Radiol 2010; 17: 496-503.
57. Emami K, Kadlecek SJ, Woodburn JM, et al. Improved technique for measurement of regional fractional ventilation by hyperpolarized 3He MRI. Magn Reson Med 2010; 63: 137-150.
58. Gierada DS, Woods JC, Bierhals AJ, et al. Effects of diffusion time on short-range hyperpolarized (3)He diffusivity measurements in emphysema. J Magn Reson Imaging 2009; 30: 801-808.
59. Miller GW, Mugler JP, Altes TA, et al. A short-breath-hold technique for lung pO2 mapping with 3He MRI. Magn Reson Med 2010; 63: 127-136.
60. Holmes JH, O'Halloran RL, Brodsky EK, et al. Three-dimensional imaging of ventilation dynamics in asthmatics using multiecho projection acquisition with constrained reconstruction. Magn Reson Med 2009; 62: 1543-1556.
61. Woodhouse N, Wild JM, van Beek EJ, Hoggard N, Barker N, Taylor CJ., Assessment of hyperpolarized 3He lung MRI for regional evaluation of interventional therapy: a pilot study in pediatric cystic fibrosis. J Magn Reson Imaging 2009; 30: 981-988.
62. Tashkin DP, de Lange EE., Imaging of the distal airways. J Allergy Clin Immunol 2009; 124: S78-83.
63. Ebner B, Behm P, Jacoby C, et al. Early assessment of pulmonary inflammation by 19F MRI in vivo. Circ Cardiovasc Imaging 2010; 3: 202-210.
64. Weber WA, Grosu AL, Czernin J., Technology insight: advances in molecular imaging and an appraisal of PET/CT scanning. Nat Clin Pract Oncol 2008; 5: 160-170.
65. Hasegawa BH, Iwata K, Wong KH, et al. Dual-modality imaging of function and physiology. Acad Radiol 2002; 9: 1305-1321.
66. Keidar Z, Israel O, Krausz Y., SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med 2003; 33: 205-218.
67. Schlemmer HP, Pichler BJ, Schmand M, et al. Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology 2008; 248: 1028-1035.
68. Lecomte R., Novel detector technology for clinical PET. Eur J Nucl Med Mol Imaging 2009; 36 (Suppl 1): S69-85.
69. Liang Z-P, Lauterbur PC., Principles of magnetic resonance imaging: a signal processing perspective. New York: Wiley IEEE-Press, 1999.
70. Hofmann M, Pichler B, Schölkopf B, Beyer T., Towards quantitative PET/MRI: a review of MR-based attenuation correction techniques. Eur J Nucl Med Mol Imaging 2009; 36: S93-S104.
71. Beyer T, Weigert M, Quick HH, Pietrzyk U., MR-based attenuation correction for torso-PET/MR imaging: pitfalls in mapping MR to CT. Eur J Nucl Med Mol Imaging 2008; 35: 1142-1146.
72. Boucher L, Rodrigue S, Lecomte R, Benard F., Respiratory gating for 3-dimensional PET of the thorax: feasibility and initial results. J Nucl Med 2004; 45: 214-219.
73. Chi PC, Mawlawi O, Luo D, Liao Z, Macapinlac HA, Pan T., Effects of respiration-averaged computed tomography on positron emission tomography/computed tomography quantification and its potential impact on gross tumor volume delineation. Int J Radiat Oncol Biol Phys 2008; 71: 890-899.
74. Nehmeh SA, Erdi YE, Pan T, et al. Four-dimensional (4D) PET/CT imaging of the thorax. Med Phys 2004; 31: 3179-3186.
75. Kinahan PE, MacDonald L, Ng L, et al. Compensating for patient respiration in PET/CT imaging with the registered and summed phases (RASP) procedure. In: 3rd IEEE International Symposium on Biomedical Imaging: Nano to Macro. Washington DC, 2006, 1104-11107.
76. Nehmeh SA, Erdi YE., Respiratory motion in positron emission tomography / computed tomography: a review. Semin Nucl Med 2008; 38: 167-176.
77. Beyer T, Antoch G, Muller S, et al. Acquisition protocol considerations for combined PET/CT imaging. J Nucl Med 2004; 45: 25S-235.
78. Kohlmyer S, Alessio A, Kinahan P, Fessler J., 4D PET temporal smoothing with respiratory induced Fourier filter (RIFF). J Nucl Med 2007; 48: 197P.
79. Liu C, Alessio A, Pierce L, et al. Quiescent phase respiratory gating for PET/CT. J Nucl Med 2009; 50: 1473P.
80. Lutterbey G, Gieseke J, von F M, Morakkabati N, Schild H., Lung MRI at 3.0 T: a comparison of helical CT and high-field MRI in the detection of diffuse lung disease. Eur Radiol 2005; 15: 324-328.